MaaT Pharma is a French biopharmaceutical company based in Lyon that develops therapies built around the human gut microbiome. Its work centres on microbiome ecosystem therapies, which use donated faecal material processed into standardized medicinal products, and it also develops related technologies for collecting and manufacturing these treatments. The company's programmes target serious conditions affecting cancer patients and others whose gut bacteria have been disrupted, and it works with hospital clinicians and research partners on clinical studies of its candidates.
The shares are listed on the Euronext Paris in France under the code MAAT, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #605 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendWeak
2/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-76.7%
From 52-week high-87.1%
MomentumWeak
3/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-63.4%
6-month return-81.1%
12-month, skipping last month-62.3%
Stability (higher is calmer)Weak
3/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)144.6%
Worst drawdown, 1 year (smaller is calmer)-88.3%
LiquidityFair
66/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.15M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 0.903 – 8.620Daily closes, split-adjusted
Signals
50-day average2.036
200-day average4.285
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.123
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
0.96
Bullish
EMA 10
0.99
Bullish
SMA 20
1.05
Bearish
EMA 20
1.18
Bearish
SMA 50
2.04
Bearish
EMA 50
1.79
Bearish
SMA 100
2.40
Bearish
EMA 100
2.54
Bearish
SMA 200
4.29
Bearish
EMA 200
3.48
Bearish
Oscillators (daily)
RSI (14)
33.49
Neutral
MACD (12, 26)
-0.29
Bearish
Momentum (12)
-2.91
Bearish
Stochastic %K (14)
34.28
Neutral
Williams %R (14)
-65.72
Neutral
CCI (20)
-33.24
Neutral
Pivot points (classic, last session)
S3
0.94
S2
0.96
S1
0.98
Pivot
1.00
R1
1.02
R2
1.05
R3
1.07
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
